| Vorinostat | IC50 | 3000.0 [1] |
| Vorinostat | Ki | 33.0 [1], 36.0 [2], 3600.0 [3], 12000.0 [4] |
| Trichostatin A | IC50 | 16.0 [1] |
| Trichostatin A | Ki | 260.0 [1], 4120.0 [2] |
| Panobinostat | IC50 | 92.0 [1], 190.0 [2], 190.3 [3], 300.0 [4] |
| Panobinostat | Ki | 0.7 [1], 57.0 [2], 80.0 [3] |
| Tubastatin A | IC50 | 30000.0 [1] |
| Tubacin | IC50 | 3350.0 [1], 30000.0 [2] |
| Tubacin | Ki | 1500.0 [1], 1919.6 [2] |
| CID 53344908 | IC50 | 80.0 [1], 108.4 [2], 263.0 [3], 990.0 [4] |
| CID 53344908 | Ki | 86.9 [1] |
| Entinostat | IC50 | 1400.0 [1], 10000.0 [2], 50000.0 [3] |
| Dacinostat | IC50 | 5.58 [1], 190.0 [2] |
| Dacinostat | Ki | 420.0 [1] |
| Romidepsin | IC50 | 10000.0 [1] |
| Romidepsin | Ki | 550.0 [1] |
| Belinostat | Ki | 25.0 [1], 175.0 [2] |
| Mocetinostat | IC50 | 10000.0 [1] |
| Ricolinostat | IC50 | 5000.0 [1], 10000.0 [2] |
| Scriptaid | IC50 | 300.0 [1] |
| Scriptaid | Ki | 1000.0 [1] |
| Quisinostat | Ki | 2.1 [1], 4.3 [2] |
| Givinostat | Ki | 600.0 [1] |
| 4-Acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | IC50 | 10000.0 [1], 20000.0 [2] |
| N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamide | IC50 | 1570.0 [1] |
| N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamide | Ki | 701.0 [1] |
| N-Hydroxy-4-phenylbutanamide | IC50 | 25000.0 [1] |
| N-Hydroxy-4-phenylbutanamide | Ki | 16000.0 [1] |
| N-Hydroxy-2,2-diphenylacetamide | IC50 | 140.0 [1], 160.0 [2] |
| CID 24853793 | IC50 | 1.0 [1], 10000.0 [2] |
| N-(4-Hydroxybiphenyl-3-yl)benzamide | IC50 | 50000.0 [1] |
| (E)-N-Hydroxy-3-[2-(2-phenylethyl)-1-(2-pyrrolidin-1-ylethyl)benzimidazol-5-yl]prop-2-enamide | Ki | 17.0 [1], 17.2 [2] |
| N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-isoquinoline-6-carboxamide | IC50 | 50000.0 [1] |
| (1r,2r,3r)-2-[4-(5-Fluoranylpyrimidin-2-Yl)phenyl]-N-Oxidanyl-3-Phenyl-Cyclopropane-1-Carboxamide | IC50 | 30.0 [1] |
| N-[[4-(Hydroxycarbamoyl)phenyl]methyl]-1-methylpyrrole-2-carboxamide | IC50 | 3300.0 [1] |
| Valproic acid | IC50 | 2000000.0 [1] |
| Butyric acid | IC50 | 2000000.0 [1] |
| 4-Phenylbutyric acid | IC50 | 2000000.0 [1] |
| Hinokitiol | Ki | 2500.0 [1] |
| N-Hydroxybenzamide | IC50 | 33330.0 [1] |
| Largazole | IC50 | 10000.0 [1] |
| Pracinostat | Ki | 21.0 [1] |
| n,n'-Dihydroxyoctanediamide | Ki | 9500.0 [1] |
| Cudc-101 | IC50 | 11.4 [1] |
| Fimepinostat | IC50 | 674.0 [1] |
| Pyroxamide | Ki | 4750.0 [1] |
| N-(2-Aminophenyl)benzamide | IC50 | 50000.0 [1] |
| 1-(3,4-Dihydroxyphenyl)-2-[(4-hydroxy-6-methylpyrimidin-2-YL)thio]ethanone | IC50 | 100000.0 [1] |
| Nexturastat A | IC50 | 11700.0 [1] |
| CID 71520717 | IC50 | 4.22 [1] |
| Azumamide E | IC50 | 10000.0 [1] |
| Nanatinostat | IC50 | 200.0 [1] |
| N-(6-(2-Aminophenylamino)-6-oxohexyl)-4-methylbenzamide | IC50 | 180000.0 [1] |
| 2-[(4-Methyl-6-oxo-1,6-dihydropyrimidin-2-yl)sulfanyl]-N-(2-phenylethyl)acetamide | IC50 | 100000.0 [1] |
| 2-[(4-Hydroxy-6-methylpyrimidin-2-yl)sulfanyl]-1-(4-methoxyphenyl)ethanone | IC50 | 100000.0 [1] |
| N-(Quinolin-8-YL)-6-(2-sulfanylacetamido)hexanamide | IC50 | 890.0 [1] |
| N-(4-Aminobiphenyl-3-yl)benzamide | IC50 | 50000.0 [1] |
| 4-[2-[2-Hydroxyethyl(Phenyl)amino]-2-Oxidanylidene-Ethyl]-~{n}-Oxidanyl-Benzamide | IC50 | 10000.0 [1] |
| N-(2-Aminophenyl)-4-[1-[2-(3-thienyl)ethyl]-1H-1,2,3-triazol-4-yl]benzamide | IC50 | 100000.0 [1] |
| N-(2-Aminophenyl)-N'-phenylheptanediamide | IC50 | 180000.0 [1] |
| N-Hydroxy-2-(4-(naphthalen-2-ylsulfonyl)piperazin-1-yl)pyrimidine-5-carboxamide | IC50 | 7.1 [1] |
| HDAC inhibitor | IC50 | 3040.0 [1] |
| N-(4-{[(4-Hydroxy-6-methylpyrimidin-2-yl)sulfanyl]acetyl}phenyl)acetamide | IC50 | 27900.0 [1] |
| CID 46852450 | IC50 | 458.0 [1] |
| (S)-Benzyl (6-acetamido-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate | IC50 | 1308.0 [1] |
| N-(2-Amino-phenyl)-nicotinamide | IC50 | 50000.0 [1] |
| 6-Methyl-2-{[2-oxo-2-(thiophen-2-yl)ethyl]sulfanyl}-3,4-dihydropyrimidin-4-one | IC50 | 100000.0 [1] |
| N-Hydroxy-5-[[6-oxo-4-(4-phenylphenyl)-1H-pyrimidin-2-yl]sulfanyl]pentanamide | IC50 | 50000.0 [1] |
| (E)-N-Hydroxy-3-[4-(4-methoxyphenyl)phenyl]prop-2-enamide | IC50 | 29600.0 [1] |
| N-[(2S)-1,8-Dioxo-1-[(4-phenyl-1,3-thiazol-2-yl)amino]nonan-2-yl]-1-methylpiperidine-2-carboxamide | IC50 | 1900.0 [1] |
| 1-Methyl-N-[(1S)-1-(5-naphthalen-2-yl-1H-imidazol-2-yl)-7-oxooctyl]piperidine-4-carboxamide | IC50 | 1.0 [1] |
| Pimelic Diphenylamide 106 | IC50 | 100000.0 [1] |
| 6-(1-Adamantylcarbamoylamino)-N-hydroxyhexanamide | IC50 | 310.0 [1] |
| N-Hydroxybutanamide | IC50 | 360000.0 [1] |
| N-Hydroxy-9H-xanthene-9-carboxamide | IC50 | 110.0 [1] |
| N-[1-[[3-Azido-5-(azidomethyl)phenyl]methyl]pyrazol-4-yl]-N'-hydroxyoctanediamide | IC50 | 892.0 [1] |
| 3-N-Hydroxy-1-N-(2-phenylethyl)benzene-1,3-dicarboxamide | IC50 | 33000.0 [1] |
| N-Hydroxy-2-propylpentanamide | IC50 | 37000.0 [1] |
| 2-Hydroxy-7-phenyl-2,4,6-cycloheptatriene-1-one | Ki | 2500.0 [1] |
| 2-Hydroxy-4-phenyl-2,4,6-cycloheptatrien-1-one | Ki | 2500.0 [1] |
| Benzamide, N-(((6-(hydroxyamino)-6-oxohexyl)amino)carbonyl)- | Ki | 46.0 [1] |
| N-[(1S)-1-[5-(2-Methoxyquinolin-3-yl)-1H-imidazol-2-yl]-7-oxononyl]-1-methylazetidine-3-carboxamide | IC50 | 10000.0 [1] |
| N-Hydroxy-4-[(quinolin-8-ylamino)methyl]benzamide | IC50 | 3112.0 [1] |
| 6-Methyl-2-phenacylsulfanyl-1H-pyrimidin-4-one | IC50 | 100000.0 [1] |
| 2-(4-Chlorophenacylthio)-4-hydroxy-6-methylpyrimidine | IC50 | 100000.0 [1] |
| Pandacostat | Ki | 180.0 [1] |
| 5-[[4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]methyl]-N-hydroxythiophene-2-carboxamide | IC50 | 10000.0 [1] |
| N-Hydroxy-7-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]octanamide | IC50 | 7400.0 [1] |
| (E)-N-Hydroxy-3-[4-(4-hydroxyphenyl)phenyl]prop-2-enamide | IC50 | 11200.0 [1] |
| 2-(4-Methoxybenzyloxy)-N8-hydroxy-N1-phenyloctanediamide | IC50 | 134.0 [1] |
| (2E,4E)-N-Hydroxy-5-[4-(4-methoxyphenyl)phenyl]penta-2,4-dienamide | IC50 | 100000.0 [1] |
| N-(2-Amino-5-thiophen-2-ylphenyl)benzamide | IC50 | 50000.0 [1] |
| N-(4-Aminobiphenyl-3-yl)nicotinamide | IC50 | 50000.0 [1] |
| N-(2-Amino-5-(thiophen-2-yl)phenyl)nicotinamide | IC50 | 50000.0 [1] |
| 3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamide | Ki | 11500.0 [1] |
| 1-[5-[3-[4-(1,3,4-Oxadiazole-2-yl)phenoxymethyl]-1,2,4-oxadiazole-5-yl]-2-thienyl]trifluoroethanone | IC50 | 10.0 [1] |
| (E)-3-[1-[3-(Dimethylamino)-2,2-dimethylpropyl]-2-(2-phenylethyl)benzimidazol-5-yl]-N-hydroxyprop-2-enamide | Ki | 16.0 [1] |
| (3S,6S,9S,13S)-9-Methyl-13-(2-methylpropyl)-3-(naphthalen-1-ylmethyl)-6-(6-oxooctyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 10000.0 [1] |
| 5-[4-[[3-Azido-5-(azidomethyl)benzoyl]amino]phenyl]-N-[7-(hydroxyamino)-7-oxoheptyl]-1,2-oxazole-3-carboxamide | IC50 | 932.0 [1] |
| (E)-N-Hydroxy-3-[4-(trifluoromethyl)phenyl]prop-2-enamide | IC50 | 34700.0 [1] |